Global Beauty Launches Are a Regulatory Minefield, Here’s How Brands Are Staying Compliant

Getting a new lipstick or moisturizer to market isn’t just about nailing the formula anymore. The real make-or-break moment often comes later, when regulators in different countries decide whether your product can legally be sold.

A formula that clears the European Union’s rules can still hit a wall in the U.S. under the Modernization of Cosmetics Regulation Act (MoCRA), or face entirely different ingredient lists and filing requirements in China and Japan. For brands and labs trying to scale internationally, compliance has become a strategic bottleneck that can slow launches, trigger costly reformulations, or block market entry altogether.

Why international cosmetic compliance has gotten so hard

Cosmetics regulation is increasingly market-by-market, with different definitions, restricted ingredients, labeling rules, and documentation requirements. In the EU, companies must maintain a Product Information File (PIF) and meet strict safety assessment standards. In the U.S., MoCRA, passed in 2022, expanded FDA oversight, including facility registration, product listing, and new safety and adverse event requirements.

That means “approved” isn’t universal. A single ingredient, concentration threshold, or marketing claim can derail a launch, often late in the process, when packaging is printed and production is scheduled.

What to look for before you pick a compliance solution

Before comparing vendors or approaches, companies need to get specific about what they’re buying. Key criteria include geographic coverage (which markets are supported), how tightly compliance is integrated into formulation work, and how much can be automated, ingredient checks, concentration limits, and claims screening.

Teams also weigh whether a tool can generate required documentation (like the EU’s PIF), how strong the regulatory monitoring is, and whether the solution can scale as a product portfolio grows.

1) Coptis: compliance built into the formulation process

Coptis positions itself as a purpose-built R&D software platform for cosmetics, designed to catch regulatory problems where they start: inside the formula. The system integrates regulatory databases, INCI naming conventions, and lists of banned or restricted ingredients so chemists and R&D teams can get alerts during development, not right before filing.

Its regulatory coverage is organized by market, including EU rules, U.S. MoCRA requirements, and frameworks tied to China and Japan. The platform also automates regulatory reports and documentation such as the EU Product Information File, while centralizing data for R&D, regulatory, and quality teams. The company says it has more than 4,500 users globally and offices in Paris, New York, and Singapore, and has added AI-driven formulation support through a tool it calls Purple AI.

2) Cosmed: an industry group approach, training, monitoring, and support

Cosmed isn’t software. It’s a major French cosmetics industry association representing roughly 1,030 companies, many of them small and mid-sized businesses. Its value proposition is collective support: regulatory monitoring, training programs, compliance tools, and help issuing “free sale” certificates used in some export contexts.

Cosmed also serves as an industry voice with French and EU authorities. For companies that need education, updates, and a structured way to stay informed, rather than a tool embedded in R&D, this model can be a fit.

3) Biorius: outsourced regulatory expertise, and a “Responsible Person” role

Biorius operates as a cosmetics regulatory consultancy, offering end-to-end support for getting products onto shelves. In Europe and the U.K., it can act as the “Responsible Person,” the legally accountable entity required for cosmetics sold in those markets. It also offers services aligned with MoCRA in the U.S., including acting as a U.S. agent.

The firm handles formula reviews, safety reports, Product Information Files, and EU portal notifications. Biorius says it has evaluated more than 50,000 products, works with more than 1,500 brands, and covers more than 60 countries, an option for companies that would rather outsource regulatory responsibility than build it in-house.

4) Belab Services: a market-access play across multiple regions

Belab Services focuses on international market access, acting as a legal representative and “Responsible Person” across several regions, including the EU, U.K., U.S., Canada, Gulf countries, and Turkey. The company prepares PIF documentation and coordinates safety testing.

Belab says it has worked on more than 500 client projects, notified more than 5,000 products, operates in more than 30 markets, and maintains eight offices worldwide. It also works beyond cosmetics, including dietary supplements and medical devices.

5) Obelis: a long-running compliance provider across sectors

Founded in 1988 and based in Brussels, Obelis provides regulatory compliance services across medical devices, cosmetics, and other categories. Like other providers in this space, it offers authorized representation and “Responsible Person” services aimed at speeding market entry while keeping companies on the right side of regulators.

Its coverage includes the EU, U.K., U.S., Switzerland, Canada, and additional markets.

So what’s the right choice?

The decision comes down to how much control a company wants, and where it wants compliance to live. If the goal is to bake regulatory checks into product development and keep R&D, regulatory, and quality teams working from the same source of truth, a formulation-integrated platform like Coptis can reduce late-stage surprises and shorten launch timelines.

If the bigger need is legal representation, market-entry paperwork, or fully outsourced expertise in one or more regions, consultancies and “Responsible Person” providers like Biorius, Belab Services, or Obelis may be the more practical route. For smaller companies trying to build internal capability, an industry association model like Cosmed can provide the training and regulatory visibility to avoid getting blindsided.